903P AL101 therapy in patients with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC): Final ACCURACY trial results and meta-analysis of clinical outcomes.
Saved in:
| Title: | 903P AL101 therapy in patients with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC): Final ACCURACY trial results and meta-analysis of clinical outcomes. |
|---|---|
| Authors: | Ferrarotto, R.1 (AUTHOR), Bobbili, P.2 (AUTHOR), Bowles, D.W.3 (AUTHOR), Even, C.4 (AUTHOR), Gordon, G.5 (AUTHOR), Gutierrez, A.6 (AUTHOR), Metcalf, R.7 (AUTHOR), Muzaffar, J.8 (AUTHOR), Nguyen, C.9 (AUTHOR), Oliva, M.10 (AUTHOR), Perez, C.A.11 (AUTHOR), Rodriguez, C.12 (AUTHOR), Sendhil, S.R.13 (AUTHOR), Winquist, E.14 (AUTHOR), Wirth, L.J.15 (AUTHOR), Xia, B.16 (AUTHOR), Yovell, J.17 (AUTHOR), Ho, A.L.18 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS575-S576. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2023.09.2048 |